Inhibition of OATP1B1-mediated uptake by macrolides

被引：0
|
作者：
Seithel, A
Mürdter, T
Fromm, MF
König, J
机构：
[1] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, Erlangen, Germany
[2] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2006年 / 372卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
535
引用
收藏
页码：137 / 137
页数：1
相关论文
共 50 条
  • [31] Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1
    Nies, Anne T.
    Niemi, Mikko
    Burk, Oliver
    Winter, Stefan
    Zanger, Ulrich M.
    Stieger, Bruno
    Schwab, Matthias
    Schaeffeler, Elke
    GENOME MEDICINE, 2013, 5
  • [32] Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1
    Anne T Nies
    Mikko Niemi
    Oliver Burk
    Stefan Winter
    Ulrich M Zanger
    Bruno Stieger
    Matthias Schwab
    Elke Schaeffeler
    Genome Medicine, 5
  • [33] Effects of Uremic Serum Residue on OATP1B1-and OATP1B3-Mediated Pravastatin Uptake in OATP-Expressing HEK293 Cells and Human Hepatocytes
    Uchiyama, Hitoshi
    Tsujimoto, Masayuki
    Kimura, Akari
    Yuki, Eriko
    Saiki, Takashi
    Yoshida, Takuya
    Furukubo, Taku
    Izumi, Satoshi
    Yamakawa, Tomoyuki
    Tachiki, Hidehisa
    Minegaki, Tetsuya
    Nishiguchi, Kohshi
    THERAPEUTIC APHERESIS AND DIALYSIS, 2019, 23 (02) : 126 - 132
  • [34] Inhibition of vectorial transport by macrolides in OATP1B3-MRP2 double transfected, polarized cells
    Eberl, S
    Mürdter, T
    Dörje, F
    König, J
    Fromm, MF
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 139 - 140
  • [35] Bosentan is a substrate of human OATP1B1 and OATP1B3:: Inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin a, rifampicin, and sildenafil
    Treiber, Alexander
    Schneiter, Ralph
    Haeusler, Stephanie
    Stieger, Bruno
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (08) : 1400 - 1407
  • [36] Static Model-Based Assessment of OATP1B1-Mediated Drug Interactions with Preincubation-Dependent Inhibitors Based on Inactivation and Recovery Kinetics
    Taguchi, Takayuki
    Masuo, Yusuke
    Futatsugi, Azusa
    Kato, Yukio
    DRUG METABOLISM AND DISPOSITION, 2020, 48 (09) : 750 - 758
  • [37] Characterization of Ursodeoxycholic and Norursodeoxycholic Acid as Substrates of the Hepatic Uptake Transporters OATP1B1, OATP1B3, OATP2B1 and NTCP
    Koenig, Joerg
    Klatt, Sabine
    Dilger, Karin
    Fromm, Martin F.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 111 (02) : 81 - 86
  • [38] Differential Preincubation Effects of Nicardipine on OATP1B1-and OATP1B3-Mediated Transport in the Presence and Absence of Protein: Implications in Assessing OATP1B1-and OATP1B3-Mediated Drug-Drug Interactions
    Kayesh, Ruhul
    Tambe, Vishakha
    Xu, Chao
    Yue, Wei
    PHARMACEUTICS, 2023, 15 (03)
  • [39] Identification, Ki determination and CoMFA analysis of nuclear receptor ligands as competitive inhibitors of OATP1B1-mediated estradiol-17β-glucuronide transport
    Gui, Chunshan
    Wahlgren, Brett
    Lushington, Gerald H.
    Hagenbuch, Bruno
    FASEB JOURNAL, 2009, 23
  • [40] Dissecting the Contribution of OATP1B1 to Hepatic Uptake of Statins Using the OATP1B1 Selective Inhibitor Estropipate
    Zhang, Yueping
    Panfen, Erika
    Fancher, Marcus
    Sinz, Michael
    Marathe, Punit
    Shen, Hong
    MOLECULAR PHARMACEUTICS, 2019, 16 (06) : 2342 - 2353
12345